Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure–Response Analysis

Fostemsavir, a prodrug of human immunodeficiency virus attachment inhibitor temsavir (TMR), is in phase III development in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type I (HIV‐1) infection in heavily treatment‐experienced adults with multidrug‐re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagishetty, Chakradhar, Moore, Katy, Ackerman, Peter, Llamoso, Cyril, Magee, Mindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359933/
https://www.ncbi.nlm.nih.gov/pubmed/32027457
http://dx.doi.org/10.1111/cts.12763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359933/
https://www.ncbi.nlm.nih.gov/pubmed/32027457
http://dx.doi.org/10.1111/cts.12763

Ejemplares similares